MedPath

Therapies for Salivary Flux Stimulation in Patients Transplanted With Hematopoietic Stem Cells

Phase 1
Withdrawn
Conditions
Mucositis
Interventions
Device: mechanical stimulation (Elastomers)
Procedure: TENS
Registration Number
NCT00929825
Lead Sponsor
Federal University of Minas Gerais
Brief Summary

The transplantation of hematopoietic stem cells (THSC) is a therapeutic modality developed for the treatment of various diseases such as leukemia, bone marrow aplasia, lymphomas, multiple myeloma, among others. Most patients who undergo the THSC usually have oral manifestations as a result of immunosuppression achieved by chemotherapy and/or radiotherapy. The most common complications are the reduction of salivary flow, mucositis and graft-versus-host disease (GVHD). These conditions can be very debilitating and interfere with medical therapy, leading to systemic complications, affecting the prognosis and increasing the length of hospitalization of the patient and the costs of treatment. To date, there is no protocol that prevents the reduction of salivary flow and minimizes the occurrence of mucositis and GVHD in these patients. This study aims to verify the effectiveness of treatment with two sialogogues (Hyperboloid and TENS \[transcutaneous electrical stimulation\]) to restore the flow and biochemical composition of saliva in patients undergoing THSC myeloablative and non-myeloablative conditionating regime.

Detailed Description

It will be included in the sample a total of 60 patients undergoing hematopoietic stem cell transplantation (THSC) at the Clinical Hospital. Patients will be randomly divided into four groups, each with 15 subjects: group I patients who will use only the mechanical sialogogue; group II patients who will make use of electrical sialogogue (TENS); group III patients who will make use of mechanical sialogogue associated with TENS and group IV patients who will not receive therapy (control).

The project will present the following experimental design:

1. Selection of patients to be subjected to the transplantation of hematopoietic stem cells;

2. Implementation of a reference sialometry;

3. Institution of therapy with mechanical and electrical sialogogue;

4. Clinical examination, assessment of the occurrence of mucositis and obtention of saliva samples pre- and post-THSC;

5. Qualitative analysis of saliva (turbidity, viscosity and color);

6. Biochemical analysis of saliva;

7. Statistical analysis of data.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients submitted to THSC at Clinical Hospital of Federal University who underwent a myeloablative or a non-myeloablative conditioning regime
  • Age over 16 years
  • Oral mucosa intact on the first day of conditioning
  • Ability to cooperate with treatment
Exclusion Criteria
  • Cases with no clinical follow up
  • Patients who refuse to participate
  • Patients with no ability to cooperate with treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Elastomers+TENSTENSPatients will receive TENS plus hyperboloid as eletric and mechanical treatment for salivary stimuli
Elastomersmechanical stimulation (Elastomers)Patients will use hyperboloid as mechanical salivary stimuli. Patients will chew hyperboloid 3 times a day
TENSTENSTENS is a eletric stimuli that will be use in the skin near to parotid glands. Patients will receive TENS treatment as eletric salivary stimuli. Patients will receive TENS stimuli once a day for 15 days
Elastomers+TENSmechanical stimulation (Elastomers)Patients will receive TENS plus hyperboloid as eletric and mechanical treatment for salivary stimuli
Primary Outcome Measures
NameTimeMethod
Salivary flux7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Dentistry of Federal University of Minas Gerais

🇧🇷

Belo Horizonte, Minas Gerais/Belo Horizonte, Brazil

© Copyright 2025. All Rights Reserved by MedPath